Creative Edge Nutrition, Inc. (OTCMKTS:FITX) Stabilizes Once More
Judging by the diminished dollar volumes and the steady loss of its market value one sizable chunk after the other for five consecutive sessions, it seemed like Creative Edge Nutrition, Inc. (OTCMKTS:FITX) would be headed down for good. Last Thursday and Friday saw the ticker bounce back to $0.038, but can FITX go on further up, or even keep this price gain?
Evidently, there were many investors that saw the company’s 52 week low as an excellent opportunity to stock up on cheap shares. This is one of the more likely explanations for the 5.56% increase share prices saw on Friday, because FITX certainly hasn’t done anything significant to warrant an upward movement recently.
Indeed, with no news of resolution on the subject of the petition to Health Canada, FITX’s situation looks more and more grim with each passing day. Unfortunately for marijuana stock enthusiasts, it seems like the situation in the pot stock sector isn’t going to get any better either – especially now that there is a possibility that the SEC is going to get actively involved with rooting out dubious pot-stocks once more.
As reported by the New York Post, companies such as Growlife Inc. (OTCMKTS:PHOT), Growblox Sciences Inc. (OTCMKTS:GBLX) and Vape Holdings Inc. (OTCMKTS:VAPE) are to be the prime targets of the “SEC’s sniff test” but, FITX supporters also have a reason to worry. After all, it’s not like Bill Chaaban and his management team haven’t said and done some pretty dubious things in the past.